Investigating the association between ALK receptor tyrosine kinase inhibitors and pulmonary arterial hypertension: a disproportionality analysis from the WHO pharmacovigilance database.
Charles KhouriAlex HlavatyMatthieu RoustitJean-Luc CracowskiMarie-Camille ChaumaisMarc HumbertI David MontaniPublished in: The European respiratory journal (2021)